Feeding Premature Infants During Non-invasive Respiratory Support
NCT ID: NCT03852641
Last Updated: 2019-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2017-10-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Feeding Length on the Oxygenation Instability Among Premature Infants
NCT03748472
To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation.
NCT05824377
Comparison of Regional Splanchnic Tissue Oxygenation Measured by NIRS in Preterm Babies Fed Bolus Versus Continuous Feeding
NCT02072109
How to Optimize Enteral Feeding of the Full Enteral Feeding Preterm Infant
NCT06760832
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
NCT06731439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bolus gavage feeds
Bolus gavage feeds over 15-30 minutes
Length of feeding
Feeds will be given via nasogastric tube over 15-30 min versus 2 hr
Continuous feeds
Continuous feeds over 2.0 hrs
Length of feeding
Feeds will be given via nasogastric tube over 15-30 min versus 2 hr
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Length of feeding
Feeds will be given via nasogastric tube over 15-30 min versus 2 hr
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Feeding\>20 ml/kg/day
Exclusion Criteria
* Unstable infants because of sepsis, central nervous system, cardiac or other significant morbidities
* Gastrointestinal morbidity such as spontaneous intestinal perforation (SIP) and necrotising enterocolitis (NEC).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liron Borenstein MD
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liron Borenstein-Levin, MD
Role: PRINCIPAL_INVESTIGATOR
Rambam Health Care Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rambam Medical Center
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Feeding on NIPPV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.